In particular, obesity and increased visceral fat are, in turn, perpetuating factors for DM2 in patients with OSA, causing leptin and insulin resistance (Berger & Polotsky, 2018; Jehan et al., 2018). This evidence concerns the gene LEP and obesity disorder.